Saurabh Agarwal

2.3k citations
44 papers · 1.3k indexed · 1 hit paper · h-index 19

Saurabh Agarwal

41 papers receiving 1.3k citations

Hit Papers

COVID-19: Characteristics and Therapeutics188202120262022202450100150

Peers

Saurabh Agarwal
Comparison fields: 5 of 117
  • Neurology 269
  • Cancer Research 207
  • Hardware and Architecture 89
  • Molecular Biology 769
  • Infectious Diseases 138
Replace Vicente Arnau with:
Vicente Arnau Spain
Aili Wang China
Toshio Okamoto Japan
Zhao Zhang China
Shuo Gu United States
Ying Zhuo China
Qiyu Jiang China
Christoph Gille Germany
Puthen V. Jithesh Qatar
Tong Zhou United States
Saurabh Agarwal relative to Vicente Arnau Spain Vicente Arnau's profile →
Citations per field
00.5×10×13.4×
Vicente Arnau · 1×
Citations per year

Countries citing papers authored by Saurabh Agarwal

Since Specialization
Citations

This map shows the geographic impact of Saurabh Agarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saurabh Agarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saurabh Agarwal more than expected).

Fields of papers citing papers by Saurabh Agarwal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saurabh Agarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saurabh Agarwal. The network helps show where Saurabh Agarwal may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Saurabh Agarwal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Saurabh Agarwal Line = papers co-authored together Saurabh Agarwal links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20223
2 20229
3 20223
4 202117
5 201828
6 201783
7
ORPHAN DRUGS: THE CURRENT GLOBAL AND INDIAN SCENARIO
20160
8 201693
9 201618
10 201618
11 201572
12 201531
13 201533
14 201348
15 201219
16 2011209
17 201012
18 200914
19 20098
20 200838

About Saurabh Agarwal

Saurabh Agarwal is a scholar working on Neurology, Cancer Research and Business and International Management, having authored 44 papers that have together received 1.3k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (19 papers), Cancer, Hypoxia, and Metabolism (11 papers), Cell death mechanisms and regulation (4 papers), Transgenic Plants and Applications (4 papers), Epigenetics and DNA Methylation (4 papers), Protein Degradation and Inhibitors (4 papers), Signaling Pathways in Disease (4 papers) and Plant tissue culture and regeneration (3 papers). The work is most often cited by research in Neurology (269 citations), Cancer Research (207 citations) and Hardware and Architecture (89 citations). Saurabh Agarwal has collaborated with scholars based in United States, India and France. Frequent co-authors include Rameswari Chilamakuri, Jason M. Shohet, José E. Moreira, Rahul Garg, Meeta S. Gupta, Todd S. Macfarlan, Eugene S. Kim, Bing Ren, D. V. Amla and Indraneel Sanyal. Their work appears in journals such as Nature Communications, Genes & Development and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026